Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind dose-finding trial of HSYA injection in acute atherosclerotic thrombotic cerebral infarction
ChiCTR2000029608Phase 2Completed
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hydroxysafflower yellow a in brain infarction and ischemic stroke (4 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: modified Rankin Scale score. Started Jul 2013; status: completed.
02
Drugs
hydroxysafflower yellow a
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR2000029608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029608.